Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine in convalescent acute myocardial infarction patients
ChiCTR1800019625Phase 4Not yet recruiting
- Sponsor
- Tianjin First Central Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ivabradine in myocardial infarction (MI) (2 arms), sponsored by Tianjin First Central Hospital. Primary endpoints: Heart rate and Blood pressure. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
ivabradine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR1800019625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019625.